Socio-Demographic, Lifestyle, and Cardiometabolic Characteristics Associated with Low-Grade Systemic Inflammation in Russian Adult Population
暂无分享,去创建一个
[1] Zenglei Zhang,et al. Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets , 2023, Frontiers in Immunology.
[2] P. Mathur,et al. The influence of inflammation on cardiovascular disease in women , 2022, Frontiers in Global Women's Health.
[3] Jau-Yuan Chen,et al. The Association between High-Sensitivity C-Reactive Protein and Metabolic Syndrome in an Elderly Population Aged 50 and Older in a Community Receiving Primary Health Care in Taiwan , 2022, International journal of environmental research and public health.
[4] Hequn Chen,et al. Increased risk of testosterone deficiency is associated with the systemic immune-inflammation index: a population-based cohort study , 2022, Frontiers in Endocrinology.
[5] M. Dichgans,et al. Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups , 2022, BMC Medicine.
[6] L. Rodríguez-Mañas,et al. Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging , 2022, International journal of molecular sciences.
[7] A. Krettek,et al. Obesity Prevalence and Associated Socio-Demographic Characteristics and Health Behaviors in Russia and Norway , 2022, International journal of environmental research and public health.
[8] Meera Shivasekar,et al. Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population. , 2022, The Journal of the Association of Physicians of India.
[9] Roddy Hiram,et al. Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease , 2022, Biomolecules.
[10] Y. Nikolaev,et al. C-reactive protein as an indicator of polymorbidity in patients with arterial hypertension , 2022, Сибирский научный медицинский журнал.
[11] A. Eggen,et al. Socioeconomic inequalities in physiological risk biomarkers and the role of lifestyles among Russians aged 35-69 years , 2022, International Journal for Equity in Health.
[12] S. J. Sojourner,et al. Smoking cessation reduces systemic inflammation and circulating endothelin-1 , 2021, Scientific Reports.
[13] A. W. Kranjac,et al. Deconstructing sex differences in C‐reactive protein trends over time , 2021, American journal of human biology : the official journal of the Human Biology Council.
[14] S. Achenbach,et al. Epidemiology of cardiovascular disease in Europe , 2021, Nature Reviews Cardiology.
[15] F. Xue,et al. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study , 2021, Frontiers in Immunology.
[16] J. Lima,et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. , 2021, European heart journal.
[17] T. Wilsgaard,et al. Heavy alcohol drinking and subclinical echocardiographic abnormalities of structure and function , 2021, Open Heart.
[18] С. А. Максимов,et al. Связь высокочувствительного С-реактивного белка с фатальными и нефатальными сердечно-сосудистыми событиями у лиц трудоспособного возраста (данные проспективного исследования ЭССЕ-РФ) , 2021 .
[19] O. Polyakova,et al. Levels of high‑sensitivity C‑reactive protein in young and middle‑aged individuals and their association with hypertension , 2021 .
[20] S. Wild,et al. What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity , 2021, BMJ Open Diabetes Research & Care.
[21] A. Kucharska,et al. Obesity and chronic inflammation crosslinking , 2021, Central-European journal of immunology.
[22] M. Vaillant,et al. Micronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHES-LUX Study , 2020, Nutrients.
[23] S. Malyutina,et al. [C-reactive protein and its associations with сardiometabolic risk factors and echocardiographic indicators of heart failure: results of "Know your heart" study in Arkhangelsk]. , 2020, Kardiologiia.
[24] J. Ioannidis,et al. Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies , 2020, European Journal of Epidemiology.
[25] Jian Huang,et al. Distribution of High-sensitivity C-reactive Protein Status in an Urban Population in China. , 2020, Biomedical and environmental sciences : BES.
[26] R. Keogh,et al. Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage , 2020, Journal of Epidemiology & Community Health.
[27] G. Kitas,et al. Exercise and inflammation. , 2020, Best practice & research. Clinical rheumatology.
[28] Deepak L. Bhatt,et al. Targeting cardiovascular inflammation: next steps in clinical translation. , 2020, European heart journal.
[29] S. Bakri,et al. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male. , 2020, Clinical nutrition ESPEN.
[30] T. Wilsgaard,et al. Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross‐Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017 , 2019, Journal of the American Heart Association.
[31] A. Maharani. Socio-economic inequalities in C-reactive protein levels: Evidence from longitudinal studies in England and Indonesia , 2019, Brain, Behavior, and Immunity.
[32] D. Levy,et al. Sex Differences in Circulating Biomarkers of Cardiovascular Disease. , 2019, Journal of the American College of Cardiology.
[33] Yi Wu,et al. The Multiple Faces of C-Reactive Protein—Physiological and Pathophysiological Implications in Cardiovascular Disease , 2019, Molecules.
[34] P. Vineis,et al. Multi-cohort study identifies social determinants of systemic inflammation over the life course , 2019, Nature Communications.
[35] T. Laatikainen,et al. Laboratory test based assessment of WHO alcohol risk drinking levels , 2019, Scandinavian journal of clinical and laboratory investigation.
[36] A. Palou,et al. A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome , 2019, Nutrients.
[37] S. Anton,et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis , 2018, Ageing Research Reviews.
[38] Aditi Singh,et al. OLR1 Gene Polymorphism and Oxidized LDL Levels in Metabolic Syndrome in Indian Population , 2018, Indian journal of endocrinology and metabolism.
[39] A. Avan,et al. Serum C‐reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice , 2018, Journal of cellular physiology.
[40] T. Clark,et al. Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18. , 2018, Wellcome open research.
[41] Carl A Latkin,et al. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. , 2017, Addictive behaviors.
[42] Yanwei Xing,et al. Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies , 2017, Front. Physiol..
[43] M. Kumari,et al. Socio-economic inequalities in C-reactive protein and fibrinogen across the adult age span: Findings from Understanding Society , 2017, Scientific Reports.
[44] A. Esteghamati,et al. Distributions of High-Sensitivity C-Reactive Protein, Total Cholesterol-HDL Ratio and 10-Year Cardiovascular Risk: National Population-Based Study. , 2017, Acta medica Iranica.
[45] C. Voermans,et al. Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[46] A. Khera,et al. Sex-Based Differences in Cardiometabolic Biomarkers , 2017, Circulation.
[47] K. Sun,et al. Inflammatory biomarkers of coronary heart disease. , 2017, Frontiers in bioscience.
[48] S. Costanzo,et al. Relative contribution of health-related behaviours and chronic diseases to the socioeconomic patterning of low-grade inflammation , 2017, International Journal of Public Health.
[49] V. Fuster,et al. Oxidized LDL Is Associated With Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance , 2016, Diabetes.
[50] S. Gangemi,et al. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity , 2016, Archivum Immunologiae et Therapiae Experimentalis.
[51] M. Fenech,et al. Low-grade inflammation, diet composition and health: current research evidence and its translation , 2015, British Journal of Nutrition.
[52] J. Goldstein,et al. A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.
[53] O. Franco,et al. Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein , 2015, PloS one.
[54] S. Legrand-Poels,et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.
[55] F. Hage. C-reactive protein and Hypertension , 2014, Journal of Human Hypertension.
[56] B. Nordestgaard,et al. Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation , 2013, Circulation.
[57] P. Barter,et al. Trends in C-reactive protein levels in US adults from 1999 to 2010. , 2013, American journal of epidemiology.
[58] L. Joseph,et al. Obesity and C‐reactive protein in various populations: a systematic review and meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[59] H. Cai,et al. Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[60] Salvatore Panico,et al. Validity of a short questionnaire to assess physical activity in 10 European countries , 2011, European Journal of Epidemiology.
[61] A. Verhoeff,et al. Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. , 2011, Atherosclerosis.
[62] H. Pavenstädt,et al. C-Reactive Protein Makes Human Endothelium Stiff and Tight , 2011, Hypertension.
[63] L. Smeeth,et al. Ancestry as a Determinant of Mean Population C-Reactive Protein Values: Implications for Cardiovascular Risk Prediction , 2010, Circulation. Cardiovascular genetics.
[64] Hynek Pikhart,et al. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample , 2010, Human immunology.
[65] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[66] Y. Shin,et al. Gender difference and determinants of C-reactive protein level in Korean adults , 2009, Clinical chemistry and laboratory medicine.
[67] Y. Ragino,et al. Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction , 2008, Bulletin of Experimental Biology and Medicine.
[68] Duk-Hee Lee,et al. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. , 2008, JAMA.
[69] B. Uppal,et al. Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus friedewald estimation , 2005, Indian Journal of Clinical Biochemistry.
[70] T. Jørgensen,et al. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study , 2007, European Journal of Clinical Nutrition.
[71] P. Ridker,et al. Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women , 2007, Hypertension.
[72] R. Spitzer,et al. The PHQ-9 , 2001, Journal of General Internal Medicine.
[73] O. Nilssen,et al. C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. , 2006, Atherosclerosis.
[74] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[75] S. Yusuf,et al. C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[76] S. Verma,et al. C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle , 2003, Circulation.
[77] A. Mainous,et al. Relation between alcohol consumption and C-reactive protein levels in the adult US population. , 2002, The Journal of the American Board of Family Practice.
[78] Tzong-Shyuan Lee,et al. Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.
[79] W. G. Wood,et al. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects. , 2000, Clinical laboratory.